Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| LEMAITRE VASCULAR INCLMAT · Entity 1927 | Senior V. P., Operations | September 03, 2026 | September 08, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
LEMAITRE VASCULAR INC
Report date September 03, 2026 · Filed September 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 11.2033 |
Reported balance
After 2026-09-03 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-09-03 · Grant · Acquired 0.9556 · Balance 11.2033 F1: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 11.1949 |
Reported balance
After 2026-09-03 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-09-03 · Grant · Acquired 0.9556 · Balance 11.1949 F2: These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 13.5014 |
Reported balance
After 2026-09-03 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-09-03 · Grant · Acquired 1.6351 · Balance 13.5014 F3: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 14.774 |
Reported balance
After 2026-09-03 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-09-03 · Grant · Acquired 1.9599 · Balance 14.774 F4: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 12.2651 |
Reported balance
After 2026-09-03 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-09-03 · Grant · Acquired 2.1927 · Balance 12.2651 F5: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 13.0157 |
Reported balance
After 2026-09-03 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-09-03 · Grant · Acquired 2.4831 · Balance 13.0157 F6: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 9.4928 |
Reported balance
After 2026-09-03 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-09-03 · Grant · Acquired 3.6735 · Balance 9.4928 F7: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F2: These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F3: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F4: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F5: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F6: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F7: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 20, 2020 Filed Jan 9, 2021 02:14 UTC Amendment | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 3 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-000447 · rdgdoc.xml · nonDerivative · entry 3 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,546 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. F1 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. Read SEC document |
| December 19, 2020 Filed Dec 24, 2020 02:14 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionDividend Equivalent Rights · Derivative | 9 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-025895 · rdgdoc.xml · derivative · entry 6 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11 Underlying: Common Stock · 9 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 19, 2018. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · shares: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 19, 2018. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 19, 2018. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 19, 2018. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 19, 2020 Filed Dec 24, 2020 02:14 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Tax withholdingCommon Stock | 75 | $37.94 | $2,845.50 |
DisclosureSEC source: 0001437749-20-025895 · rdgdoc.xml · nonDerivative · entry 2 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,543 F2 · shares: These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on December 19, 2018. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. Read SEC document |
| December 19, 2020 Filed Dec 24, 2020 02:14 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 9 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-025895 · rdgdoc.xml · nonDerivative · entry 1 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,618 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. F1 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. Read SEC document |
| December 19, 2020 Filed Dec 28, 2020 23:15 UTC Amendment | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionDividend Equivalent Rights · Derivative | 9 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-025990 · rdgdoc.xml · derivative · entry 7 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11 Underlying: Common Stock · 9 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 19, 2018. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · shares: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 19, 2018. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 19, 2018. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 19, 2018. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 19, 2020 Filed Dec 28, 2020 23:15 UTC Amendment | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Tax withholdingCommon Stock | 75 | $37.94 | $2,845.50 |
DisclosureSEC source: 0001437749-20-025990 · rdgdoc.xml · nonDerivative · entry 2 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,543 F2 · shares: These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on December 19, 2018. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. Read SEC document |
| December 19, 2020 Filed Dec 28, 2020 23:15 UTC Amendment | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 9 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-025990 · rdgdoc.xml · nonDerivative · entry 1 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,618 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. F1 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. Read SEC document |
| December 19, 2020 Filed Jan 9, 2021 02:14 UTC Amendment | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionDividend Equivalent Rights · Derivative | 9 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-000447 · rdgdoc.xml · derivative · entry 7 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11 Underlying: Common Stock · 9 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 19, 2018. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · shares: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 19, 2018. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 19, 2018. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 19, 2018. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 19, 2020 Filed Jan 9, 2021 02:14 UTC Amendment | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Tax withholdingCommon Stock | 75 | $37.94 | $2,845.50 |
DisclosureSEC source: 0001437749-21-000447 · rdgdoc.xml · nonDerivative · entry 2 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,543 F2 · shares: These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on December 19, 2018. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. Read SEC document |
| December 19, 2020 Filed Jan 9, 2021 02:14 UTC Amendment | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 9 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-000447 · rdgdoc.xml · nonDerivative · entry 1 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,618 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. F1 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. Read SEC document |
| December 03, 2020 Filed Dec 4, 2020 22:45 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 2 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-024879 · rdgdoc.xml · derivative · entry 6 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9 Underlying: Common Stock · 2 shares Expires not disclosed F6 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/20/2019 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F6 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/20/2019 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F6 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/20/2019 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 03, 2020 Filed Dec 4, 2020 22:45 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 2 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-024879 · rdgdoc.xml · derivative · entry 5 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20 Underlying: Common Stock · 2 shares Expires not disclosed F5 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/19/2018 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/19/2018 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/19/2018 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 03, 2020 Filed Dec 4, 2020 22:45 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 1 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-024879 · rdgdoc.xml · derivative · entry 4 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9 Underlying: Common Stock · 1 shares Expires not disclosed F4 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/22/2017 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/22/2017 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/22/2017 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 03, 2020 Filed Dec 4, 2020 22:45 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 1 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-024879 · rdgdoc.xml · derivative · entry 3 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9 Underlying: Common Stock · 1 shares Expires not disclosed F3 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 7/25/2016 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 7/25/2016 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 7/25/2016 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 02, 2020 Filed Dec 4, 2020 22:45 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantStock Option (Right to Buy) · Derivative | 6,148 | $0.00 Strike: $37.29 | $0.00 |
DisclosureSEC source: 0001437749-20-024879 · rdgdoc.xml · derivative · entry 2 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,148 Underlying: Common Stock · 6,148 shares Expires 2027-12-02 F2 · derivative.exercise_date: This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining four years. Read SEC document |
| December 02, 2020 Filed Dec 4, 2020 22:45 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantCommon Stock | 771 | $37.29 | $28,750.59 |
DisclosureSEC source: 0001437749-20-024879 · rdgdoc.xml · nonDerivative · entry 1 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,609 F1 · shares: Represents a restricted stock unit award that vests on a time-based schedule as follows: 20% of the award vests on the anniversary of the grant date listed in the table, with the balance vesting in equal annual installments over the remaining four years. This award includes a provision for the withholding of shares by the Issuer to pay the withholding taxes due on each vesting date. Read SEC document |
| November 24, 2020 Filed Nov 26, 2020 02:09 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | SaleCommon Stock | 18,609 | $39.99 | $744,157.16 |
DisclosureSEC source: 0001437749-20-024487 · rdgdoc.xml · nonDerivative · entry 1 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,838 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan established by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $39.45 to $40.53. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. Read SEC document |
| September 10, 2020 Filed Sep 14, 2020 23:42 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 2 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-019697 · rdgdoc.xml · derivative · entry 4 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7 Underlying: Common Stock · 2 shares Expires not disclosed F4 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/20/2019 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/20/2019 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/20/2019 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| September 10, 2020 Filed Sep 14, 2020 23:42 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 2 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-019697 · rdgdoc.xml · derivative · entry 3 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18 Underlying: Common Stock · 2 shares Expires not disclosed F3 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/19/2018 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/19/2018 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/19/2018 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| September 10, 2020 Filed Sep 14, 2020 23:42 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 1 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-019697 · rdgdoc.xml · derivative · entry 2 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8 Underlying: Common Stock · 1 shares Expires not disclosed F2 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/22/2017 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/22/2017 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/22/2017 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| September 10, 2020 Filed Sep 14, 2020 23:42 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 1 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-019697 · rdgdoc.xml · derivative · entry 1 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8 Underlying: Common Stock · 1 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 7/25/2016 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 7/25/2016 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 7/25/2016 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| July 25, 2020 Filed Jul 29, 2020 01:12 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionDividend Equivalent Rights · Derivative | 12 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-015890 · rdgdoc.xml · derivative · entry 4 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7 Underlying: Common Stock · 12 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 7/25/2016. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · shares: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 7/25/2016. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 7/25/2016. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 7/25/2016. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| July 25, 2020 Filed Jul 29, 2020 01:12 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Tax withholdingCommon Stock | 123 | $31.91 | $3,924.93 |
DisclosureSEC source: 0001437749-20-015890 · rdgdoc.xml · nonDerivative · entry 3 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,447 F3 · shares: These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on July 25, 2016. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. Read SEC document |
| July 25, 2020 Filed Jul 29, 2020 01:12 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 12 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-015890 · rdgdoc.xml · nonDerivative · entry 2 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,570 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. F2 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. Read SEC document |
| July 24, 2020 Filed Jul 29, 2020 01:12 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | SaleCommon Stock | 13,804 | $33.00 | $455,532.00 |
DisclosureSEC source: 0001437749-20-015890 · rdgdoc.xml · nonDerivative · entry 1 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,558 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan established by the Reporting Person. Read SEC document |
| June 04, 2020 Filed Jun 9, 2020 00:00 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 2 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-012673 · rdgdoc.xml · derivative · entry 4 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5 Underlying: Common Stock · 2 shares Expires not disclosed F4 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/20/2019 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/20/2019 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/20/2019 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| June 04, 2020 Filed Jun 9, 2020 00:00 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 3 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-012673 · rdgdoc.xml · derivative · entry 3 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16 Underlying: Common Stock · 3 shares Expires not disclosed F3 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/19/2018 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/19/2018 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/19/2018 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| June 04, 2020 Filed Jun 9, 2020 00:00 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 1 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-012673 · rdgdoc.xml · derivative · entry 2 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7 Underlying: Common Stock · 1 shares Expires not disclosed F2 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/22/2017 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/22/2017 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/22/2017 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| June 04, 2020 Filed Jun 9, 2020 00:00 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 2 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-012673 · rdgdoc.xml · derivative · entry 1 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19 Underlying: Common Stock · 2 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 7/25/2016 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 7/25/2016 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 7/25/2016 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| March 19, 2020 Filed Mar 23, 2020 15:16 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 3 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-005846 · rdgdoc.xml · derivative · entry 4 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3 Underlying: Common Stock · 3 shares Expires not disclosed F4 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/20/2019 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/20/2019 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/20/2019 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| March 19, 2020 Filed Mar 23, 2020 15:16 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 4 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-005846 · rdgdoc.xml · derivative · entry 3 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13 Underlying: Common Stock · 4 shares Expires not disclosed F3 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/19/2018 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/19/2018 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/19/2018 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| March 19, 2020 Filed Mar 23, 2020 15:16 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 2 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-005846 · rdgdoc.xml · derivative · entry 2 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6 Underlying: Common Stock · 2 shares Expires not disclosed F2 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/22/2017 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/22/2017 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/22/2017 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| March 19, 2020 Filed Mar 23, 2020 15:16 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 3 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-005846 · rdgdoc.xml · derivative · entry 1 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17 Underlying: Common Stock · 3 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 7/25/2016 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 7/25/2016 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 7/25/2016 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| February 20, 2020 Filed Feb 24, 2020 21:01 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionStock Option (Right to Buy) · Derivative | 4,168 | $0.00 Strike: $14.13 | $0.00 |
DisclosureSEC source: 0001437749-20-003368 · rdgdoc.xml · derivative · entry 7 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,601 Underlying: Common Stock · 4,168 shares Expires 2023-07-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, and the balance vesting in equal annual installments over the remaining four years. Read SEC document |
| February 20, 2020 Filed Feb 24, 2020 21:01 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionStock Option (Right to Buy) · Derivative | 10,979 | $0.00 Strike: $11.43 | $0.00 |
DisclosureSEC source: 0001437749-20-003368 · rdgdoc.xml · derivative · entry 6 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,274 Underlying: Common Stock · 10,979 shares Expires 2022-07-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, and the balance vesting in equal annual installments over the remaining four years. Read SEC document |
| February 20, 2020 Filed Feb 24, 2020 21:01 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,858 | $0.00 Strike: $7.87 | $0.00 |
DisclosureSEC source: 0001437749-20-003368 · rdgdoc.xml · derivative · entry 5 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 287 Underlying: Common Stock · 2,858 shares Expires 2021-07-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| February 20, 2020 Filed Feb 24, 2020 21:01 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | SaleCommon Stock | 14,225 | $31.00 | $440,975.00 |
DisclosureSEC source: 0001437749-20-003368 · rdgdoc.xml · nonDerivative · entry 4 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,362 Read SEC document |
| February 20, 2020 Filed Feb 24, 2020 21:01 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 4,168 | $14.13 | $58,893.84 |
DisclosureSEC source: 0001437749-20-003368 · rdgdoc.xml · nonDerivative · entry 3 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,587 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. Read SEC document |
| February 20, 2020 Filed Feb 24, 2020 21:01 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 10,979 | $11.43 | $125,489.97 |
DisclosureSEC source: 0001437749-20-003368 · rdgdoc.xml · nonDerivative · entry 2 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,419 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. Read SEC document |
| February 20, 2020 Filed Feb 24, 2020 21:01 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 2,858 | $7.87 | $22,492.46 |
DisclosureSEC source: 0001437749-20-003368 · rdgdoc.xml · nonDerivative · entry 1 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,440 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. Read SEC document |
| December 22, 2019 Filed Dec 26, 2019 16:17 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionDividend Equivalent Rights · Derivative | 4 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-19-024867 · rdgdoc.xml · derivative · entry 3 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4 Underlying: Common Stock · 4 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 22, 2017. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · shares: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 22, 2017. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 22, 2017. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 22, 2017. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 22, 2019 Filed Dec 26, 2019 16:17 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Tax withholdingCommon Stock | 56 | $35.48 | $1,986.88 |
DisclosureSEC source: 0001437749-19-024867 · rdgdoc.xml · nonDerivative · entry 2 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,582 F2 · shares: These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on December 22, 2017. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. Read SEC document |
| December 22, 2019 Filed Dec 26, 2019 16:17 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 4 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-19-024867 · rdgdoc.xml · nonDerivative · entry 1 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,638 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. F1 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. Read SEC document |
| December 20, 2019 Filed Dec 24, 2019 01:36 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantStock Option (Right to Buy) · Derivative | 6,765 | $0.00 Strike: $35.48 | $0.00 |
DisclosureSEC source: 0001437749-19-024839 · rdgdoc.xml · derivative · entry 5 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,765 Underlying: Common Stock · 6,765 shares Expires 2026-12-20 F5 · derivative.exercise_date: This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining four years. Read SEC document |
| December 20, 2019 Filed Dec 24, 2019 01:36 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantCommon Stock | 810 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-19-024839 · rdgdoc.xml · nonDerivative · entry 3 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,634 F3 · shares: Represents a restricted stock unit award that vests on a time-based schedule as follows: 20% of the award vests on the anniversary of the grant date listed in the table, with the balance vesting in equal annual installments over the remaining four years. This award includes a provision for the withholding of shares by the Issuer to pay the withholding taxes due on each vesting date. Read SEC document |
| December 19, 2019 Filed Dec 24, 2019 01:36 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionDividend Equivalent Rights · Derivative | 4 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-19-024839 · rdgdoc.xml · derivative · entry 4 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9 Underlying: Common Stock · 4 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 19, 2018. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · shares: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 19, 2018. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 19, 2018. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 19, 2018. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 19, 2019 Filed Dec 24, 2019 01:36 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Tax withholdingCommon Stock | 73 | $35.83 | $2,615.59 |
DisclosureSEC source: 0001437749-19-024839 · rdgdoc.xml · nonDerivative · entry 2 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,824 F2 · shares: These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on December 19, 2018. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. Read SEC document |
| December 19, 2019 Filed Dec 24, 2019 01:36 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 4 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-19-024839 · rdgdoc.xml · nonDerivative · entry 1 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,897 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. F1 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. Read SEC document |
| December 05, 2019 Filed Dec 9, 2019 21:22 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 3 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-19-024078 · rdgdoc.xml · derivative · entry 3 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13 Underlying: Common Stock · 3 shares Expires not disclosed F3 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/19/2018 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/19/2018 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/19/2018 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 05, 2019 Filed Dec 9, 2019 21:22 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 2 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-19-024078 · rdgdoc.xml · derivative · entry 2 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8 Underlying: Common Stock · 2 shares Expires not disclosed F2 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/22/2017 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/22/2017 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/22/2017 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.